Turnover
≈ €180,000 estimated
The micro format states no turnover.
KCMédical
Lifetime
2 annual accounts with figures on one time axispeak €81,330 (2024)
€59,855▼ 26.4%
peak €49,695 (2024)
€37,426▼ 24.7%
peak €91,120 (2025)
€91,120▲ 69.7%
€57,508▼ 32.5%
Board1 name since 2023
1 directorKarine TONDEUR
Documentsfilings and deeds
11-12-202551 days before the deadline
2025micro format
Gross margin from €81,330 to €59,855Equity from €53,695 to €91,120Debts from €85,157 to €57,508Cash from €13,553 to €28,648
Key points
from the 2025 annual accountsLiquidity
3.18 was 1.36 in 2024
Short-term debts fell from €67,406 to €35,307.
Starting capital
€4,000 100 shares
Checked score
69
Healthy
Financially stronger than 73% of micro companies without a NACE code
Probability in this band: 0.55% to 1.5%
Bankruptcy probability within 12 months
0.9% Low
0%0.5%1.5%4%10%≥ 25%
About 9 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 2.9%highest value
01-2025: 1.2%▼ -1.7 percentage points vs 12-2024
02-2025: 1.2%● unchanged vs 01-2025
03-2025: 1.2%● unchanged vs 02-2025
04-2025: 1.2%● unchanged vs 03-2025
05-2025: 1.2%● unchanged vs 04-2025
06-2025: 1.2%● unchanged vs 05-2025
07-2025: 1.2%● unchanged vs 06-2025
08-2025: 1.2%● unchanged vs 07-2025
09-2025: 1.5%▲ +0.3 percentage points vs 08-2025
10-2025: 1.5%● unchanged vs 09-2025
11-2025: 1.6%▲ +0.1 percentage points vs 10-2025
12-2025: 1.6%● unchanged vs 11-2025
01-2026: 0.8%▼ -0.8 percentage points vs 12-2025
02-2026: 0.8%● unchanged vs 01-2026
03-2026: 0.8%● unchanged vs 02-2026
04-2026: 0.8%● unchanged vs 03-2026
05-2026: 0.7%▼ -0.1 percentage points vs 04-2026
06-2026: 0.7%● unchanged vs 05-2026lowest value
07-2026: 0.7%● unchanged vs 06-2026
08-2026: 0.7%● unchanged vs 07-2026
09-2026: 0.8%▲ +0.1 percentage points vs 08-2026
10-2026: 0.9%▲ +0.1 percentage points vs 09-2026
11-2026: 0.9%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Founded in 2023
Profit of €37,426 (financial year 2025)
lowers risk
Liquidity: current ratio 3.18, cash €28,648
Size: total assets €148,628
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 52% of them on solvency, 62% on liquidity, 90% on profitability and 89% on growth.
The bankruptcy probability was computed on 06-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 30-06-2025.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 39,278 companies had the same profile as KCMédical has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
That fits the bankruptcy probability of KCMédical itself: 0.9% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for KCMédical. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €6,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.18 (1.36 in 2024), above the usual 1.5. Short-term debt is 23.8% and cash 19.3% of total assets. 38.7% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 11-12-2025, 51 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
51 days early
2024
52 days early
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 2 accounts on average 52 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
30-06-2026 year end07-11-2026 today31-01-2027 deadline
Board and ownership
- TONDEUR Karine Françoise founderdeed of 30-08-2023
- Karine TONDEUR 100 sharesdeed of 30-08-2023
Recent changes
Incorporation
Founding capital of €4,000, 100 shares · Founder: TONDEUR Karine Françoise · Appointment: TONDEUR Karine Françoise (director) · published on 30-08-2023 · Gazette deed
First establishment
Rue des Pinsons 5, Thuin
Official details
Source: KBO- Status
- Active since 28-08-2023Normal situation
- Activity
- “Toutes activités se rapportant directement ou indirectement à la dispensation de soins de santé…” (deed in French)From the articles, 5 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.348.835.1056534 Thuin, since 28-08-2023
- Financial year end
- 30 June
- Peppol
- Not found in the Peppol Directory
Annual accounts to 30-06-2025
- €148,628▲ 7.0%
- Filing
- Filed on 11-12-2025, 51 days before the end of the filing period
Insights on KCMédical
KCMédical has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €91,120 and a net result of €37,426.
The computed 12-month bankruptcy probability is 0.9% (low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about KCMédical
- What is the company number of KCMédical?
- The company number of KCMédical is 0805.169.977. The VAT number is the same number with BE in front: BE 0805.169.977.
- Where is KCMédical based?
- The registered office is at Rue des Pinsons 5, 6534 Thuin.Company details
- What is the legal form of KCMédical?
- KCMédical is a private limited company (BV).
- When was KCMédical founded?
- KCMédical was founded on 28-08-2023.
- Is KCMédical still active?
- Yes, KCMédical is an active enterprise in the KBO register.
- What is the turnover of KCMédical?
- The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €59,855 and 2,663 comparable companies of the same size. It probably lies between €120,000 and €310,000. It is a rough estimate.Financials
- Is KCMédical profitable?
- In financial year 2025, KCMédical made a profit of €37,426.
- Where can I find the annual accounts of KCMédical?
- KCMédical filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of KCMédical due?
- KCMédical must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.